about
Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosisSelective light-induced modulation of bcl-XL and bax expressions in indocyanine green-loaded U937 cells: effects of continuous or intermittent photo-sensitization with low IR-light using a 805-nm diode laser.Photo-activation of hypericin with low doses of light promotes apparent photo-resistance in human histiocytic lymphoma U937 cells.Down-regulation of wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in regulating several p53-dependent functions in premature senescent tumor cells.A biochemical and cellular approach to explore the antiproliferative and prodifferentiative activity of Aloe arborescens leaf extract.Human rpL3 induces G₁/S arrest or apoptosis by modulating p21 (waf1/cip1) levels in a p53-independent manner.Combination of photodynamic therapy with aspirin in human-derived lung adenocarcinoma cells affects proteasome activity and induces apoptosis.Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells.Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299).Roscovitine modulates DNA repair and senescence: implications for combination chemotherapy.Bcl-2 exerts a pRb-mediated cell cycle inhibitory function in HEC1B endometrial carcinoma cells.Lactobacillus gasseri SF1183 affects intestinal epithelial cell survival and growth.Identification of differentially expressed mRNAs in normal and neoplastic (adenocarcinoma) human endometriumProbing the interaction of thyroglobulin with metal ions by terbium(III) luminescence spectroscopyCentral role of the scaffold protein tumor necrosis factor receptor-associated factor 2 in regulating endoplasmic reticulum stress-induced apoptosis
P50
Q28261784-F06F589F-B9CA-4EDF-9B0D-4767A22F009CQ30973136-238C8711-DFDA-4A88-BF14-2F1ED89B06CFQ30996891-A9ACCED0-26B4-4E4B-A81F-6CD8FAD6261DQ39161605-BA522C7E-5FDE-40D2-8F6E-2EB70482CF92Q39192793-D2FAD118-BC6D-4FCA-AA3A-977F3B6EE033Q39223249-3A502105-F6AF-4D61-9FD5-8EB8494EB5C6Q39649112-8EA03888-0C89-4748-A14F-E3A6EC6FF3ADQ40217236-CD430FAF-0A76-4980-A359-6301FB03AC25Q40302555-1F8B4CBD-FD31-440C-8006-C3297F43E72AQ40349184-DA5F1132-AA86-45C7-BB23-0F27E6A95862Q40809181-59BE8823-FAE0-4161-B3E5-A7F65FEDA776Q43077994-0B4D725B-2EB3-4B01-9E4B-3C57D4E6DF67Q71763531-D3CAA100-5E42-4BC6-AA13-FF2414C8C3F5Q77179663-3D4FE57C-FC26-466E-8E81-297ACDA950B5Q81507240-ECB36E68-7227-490D-8773-5818280BF047
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-9258-8053
@en
name
Elvira Crescenzi
@ast
Elvira Crescenzi
@en
Elvira Crescenzi
@es
Elvira Crescenzi
@nl
type
label
Elvira Crescenzi
@ast
Elvira Crescenzi
@en
Elvira Crescenzi
@es
Elvira Crescenzi
@nl
prefLabel
Elvira Crescenzi
@ast
Elvira Crescenzi
@en
Elvira Crescenzi
@es
Elvira Crescenzi
@nl
P106
P1153
7003586939
P31
P496
0000-0002-9258-8053